Vermeulen, C., van Geloven, N., Mertens, B., Spelmink, S. E., Schipperus, M. R., Janssen, M. P., Kerkhoffs, J.-L. H., den Besten, G., van den Bos, A. G., Korver-Keularts, I. M. L. W., van de Kerkhof, D., Klinkspoor, H. J. H., De Vooght, K. M. K., van Gammeren, A. J., Russcher, H., Heijnen, J. W. M., de Korte, D., van Der Meer, P. F., & Klei, T. R. L. (2025). Clinical evaluation of red cell concentrates in non-DEHP plasticized containers compared with standard DEHP plasticized containers: A quasi-randomized observational multicentre study. Vox Sanguinis, 120(11), 1183-1188. https://doi.org/10.1111/vox.70019

Tingen, H. S. A., Berends, M., Tubben, A., van der Meer, P., Slart, R. H. J. A., Bijzet, J., van der Zwaag, P. A., Kimmich, C., Knackstedt, C., Muntinghe, F. L. H., Houwerzijl, E. J., Hazenberg, B. P. C., & Nienhuis, H. L. A. (2025). Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging, 52(13), 5000-5005. https://doi.org/10.1007/s00259-025-07328-6

Gigli, M., Verdonschot, J. A. J., Garcia-Pavia, P., Stolfo, D., Monserrat, L., Prasad, S., Mazzanti, A., Asselbergs, F. W., Bauce, B., Charron, P., Dawson, D., Halliday, B. P., Mestroni, L., Seferovic, P., Tayal, U., Esteban, M. T. T., Van Tintelen, P., Heymans, S., Pantazis, A., ... Sinagra, G. (2025). Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC. European journal of heart failure, 27(11), 2229-2243. https://doi.org/10.1002/ejhf.70042

Setti, M., Iseppi, M., Verdonschot, J. A. J., Rizzi, J. G., Paldino, A., Gava, C. P. L. D., Barbati, G., Dal Ferro, M., Venner, M. F. G. H. M., Raafs, A. G., Gigli, M., Stolfo, D., De Luca, A., De Angelis, G., Capovilla, T. M., Graw, S., Ribichini, F. L., Taylor, M., Mestroni, L., ... Merlo, M. (2025). Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy. European journal of heart failure, 27(11), 2571-2581. Article 3671. https://doi.org/10.1002/ejhf.3671

Chua, A. P. A., Weerts, J., Achten, A., Nabeta, T., Sarrazyn, C., Lopez-Santi, P., Mourmans, S. G. J., Su, J. L., Bax, J. J., Knackstedt, C., van Empel, V. P. M., & Ajmone-Marsan, N. (2025). Left Atrial Strain Index in Patients with Heart Failure with Preserved Ejection Fraction. Journal of the American Society of Echocardiography, 38(11), 1099-1101. https://doi.org/10.1016/j.echo.2025.07.008

Adamo, M., Pagnesi, M., Chioncel, O., Bayes-Genis, A., Abdelhamid, M., Antohi, E.-L., Bucciarelli-Ducci, C., Chieffo, A., Cosyns, B., Gilard, M., Grapsa, J., Gonzalez, A., Gustafsson, F., Iung, B., Joner, M., Karam, N., Lund, L. H., Maisano, F., Moura, B., ... Metra, M. (2025). Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. European journal of heart failure, 27(11), 2623-2633. https://doi.org/10.1002/ejhf.70023

Beverborg, N. G., Alnuwaysir, R. I. S., Markousis-Mavrogenis, G., Hoes, M. F., van Der Wal, H. H., Romaine, S. P. R., Nath, M., Koekoemoer, A., Cleland, J. G. F., Lang, C. C., Anker, S. D., Dickstein, K., Metra, M., Ng, L. L., van Veldhuisen, D. J., Voors, A. A., Samani, N. J., & van Der Meer, P. (2025). The transcriptional profile of iron deficiency in patients with heart failure: Heme-sparing and reduced immune processes. European journal of heart failure, 27(11), 2313-2324. https://doi.org/10.1002/ejhf.3562

Schoonvelde, S. A. C., Nollet, E. E., Zwetsloot, P. P., Knackstedt, C., Germans, T., Hirsch, A., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., van der Velden, J., & Michels, M. (2025). Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression. International Journal of Cardiology, 437, Article 133444. https://doi.org/10.1016/j.ijcard.2025.133444

Heymans, A. B. M., Bianchi, L., Volders, P. G. A., van der Crabben, S. N., & Verdonschot, J. A. J. (2025). SCN5A Cardiomyopathy: from Ion Channel Dysfunction To Clinical Disease. Current Cardiology Reports, 27(1), Article 138. https://doi.org/10.1007/s11886-025-02298-5

Gawalko, M., Habibi, Z., Verhaert, D. V. M., Engels, M., Weerts, J., Adriaans, B., Chaldoupi, S.-M., ter Bekke, R. M. A., Den Uijl, D. W., Luermans, J. G. L. M., Van Empel, V. P. M., Schotten, U., Vernooy, K., & Linz, D. (2025). Discordance between left atrial pressure and risk scores in assessment of heart failure with preserved ejection fraction in patients with atrial fibrillation undergoing catheter ablation. EP Europace, 27(10), Article euaf245. https://doi.org/10.1093/europace/euaf245

Sikking, M., Wiethoff, I., Henkens, M., Evers, S., Stroeks, S., Venner, M., Weerts, J., Brunner-la Rocca, H.-P., Knackstedt, C., van Empel, V., Michels, M., Heymans, S., Hiligsmann, M., & Verdonschot, J. (2025). High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies. Quality of Life Research, 34(10), 2901-2910. https://doi.org/10.1007/s11136-025-04027-5

D'Italia, G., Coenen, D. M., Lemmens, T. P., Brandts, L., Wielders, S. J. H., Nagy, M., Mourmans, S. G. J., Achten, A., Al-Abadi, A., Weerts, J., Aizpurua, A. B., van Empel, V., Schroen, B., & Cosemans, J. M. E. M. (2025). Immuno-haemostatic dysregulation in heart failure with preserved ejection fraction. Esc heart failure, 12(5), 3444-3460. https://doi.org/10.1002/ehf2.15361

van Koll, J., Engels, M. D. E. A., Rijks, J. H. J., Salari, M., Luijten, J., Lumens, J., van Empel, V. P. M., Westra, S. W., van Stipdonk, A. M. W., Lankveld, T. A. R., Chaldoupi, S. M., Joza, J., Beukema, R. J., Luermans, J. G. L. M., Linz, D. K., & Vernooy, K. (2025). Long-term outcomes of pace-and-ablate strategy in patients with atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 68(7), 1487-1495. Article 100786. https://doi.org/10.1007/s10840-025-02038-3

Perotto, M., Paldino, A., Mazzarotto, F., Barbati, G., Stroeks, S. L. V. M., Verdonschot, J. A. J., Akhtar, M., Elliott, P., Ochoa, J. P., Garcia-Pavia, P., de Frutos, F., Sepp, R., Hategan, L., Prasad, S., Yazdani, M., Morris-Rosendahl, D., Palinkas, E. D., Girolami, F., Olivotto, I., ... Dal Ferro, M. (2025). Genetic and Phenotypic Characterization of Nexilin (NEXN)–Related Cardiomyopathy: Results From a Multicentric Study. JACC: Heart Failure, 13(9), Article 102529. https://doi.org/10.1016/j.jchf.2025.102529

Karakasis, P., Lefkou, E., Pamporis, K., Farmakis, D., Patoulias, D., Antoniadis, A. P., Heymans, S., Filippatos, G., & Fragakis, N. (2025). Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis. European journal of heart failure, 27(9), 1775-1785. https://doi.org/10.1002/ejhf.3637

Mostert, D., van der Putten, C., Kurniawan, N. A., Lässer, C., & Bouten, C. V. C. (2025). Bioengineering structural anisotropy in living tissues. Nature reviews bioengineering, 3(9), 727-741. https://doi.org/10.1038/s44222-025-00338-x

Gilani, K., Verket, M., Peters, C., Dumontier, M., Rocca, H. P. B. L., & Urovi, V. (2025). CDE-Mapper: Using retrieval-augmented language models for linking clinical data elements to controlled vocabularies. Computers in Biology and Medicine, 196, Article 110745. https://doi.org/10.1016/j.compbiomed.2025.110745

Slob, B. P. H., Postma, M. J., Weersma, M., Rocca, H.-P. B.-L., de Jong, L. A., & Boersma, C. (2025). Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands. American journal of cardiovascular drugs : drugs, devices, and other interventions, 25(5), 715-726. https://doi.org/10.1007/s40256-025-00749-6

Aukes, R., Albersen, M., Boelen, A., Kluijtmans, L. A. J., Visser, W. F., de Vries, M. C., Bosch, A. M., C5-OH NBS Working Group, Keularts, I., Panis, B., & Gozalbo, E. R. (2025). Evaluation of Newborn Screening for Diseases Using C5-OH as a Marker: Systematic Review of the Literature and Evaluation of 17 Years of C5-OH Screening in the Netherlands. Journal of Inherited Metabolic Disease, 48(5), Article e70088. https://doi.org/10.1002/jimd.70088

Fragasso, G., Stolfo, D., Anker, M. S., Bayes-Genis, A., Chioncel, O., Heymans, S., Jhund, P. S., Lewis, B. S., Lopaschuk, G. D., Lund, L. H., Gonzalez, A., Pagnesi, M., Schiattarella, G. G., Tocchetti, C. G., van Der Meer, P., Von Linthout, S., Wassmann, S., Westenbrink, B. D., Metra, M., ... Savarese, G. (2025). The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC. European journal of heart failure, 27(9), 1700-1719. https://doi.org/10.1002/ejhf.3703

Poggiali, B., Dupont, M. E., Kampmann, M.-L., Vidaki, A., Pereira, V., Børsting, C., Tfelt-Hansen, J., & Andersen, J. D. (2025). Evaluation of the HumanMethylationEPIC v2.0 Bead Chip Using Low Quality and Quantity DNA Samples. Biological Procedures Online, 27(1), Article 34. https://doi.org/10.1186/s12575-025-00292-3

Geraeds, C. B. G., Bruninx, A., Dekker, A. L. A. J., Barandiaran Aizpurua, A., Bermejo, I., & Brunner-La Rocca, H.-P. (2025). Exploring safety of down-titrating diuretics in heart failure management. European journal of heart failure, 27(8), 1393-1399. https://doi.org/10.1002/ejhf.3714

Weerts, J., Schroen, B. L. M., Barandiaran Aizpurua, A., Berendschot, T. T. J. M., Brandts, L., Webers, C. A. B., Simons, S. O., Meex, S. J. R., Henry, R., van der Kallen, C. J. H., Brunner-La Rocca, H.-P., Knackstedt, C., Heymans, S. R. B., de Boer, R. A., van Empel, V. P. M., & Houben, A. J. H. M. (2025). Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study. Cardiovascular Diabetology, 24(1), Article 310. https://doi.org/10.1186/s12933-025-02850-1

Venner, M. F. G. H. M., Gevers, T. J. G., Ploum, F., Habets, J., Raafs, A. G., Weerts, J., Heymans, S. R. B., van der Leij, C., de Haan, M. W., Verdonschot, J. A. J., Kramer, M., & Knackstedt, C. (2025). Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 431, Article 133226. https://doi.org/10.1016/j.ijcard.2025.133226

Pencheva, M. G., Berends, E., van der Laan, K. W. F., Giudici, A., Niessen, P., Scheijen, J. L. J. M., Vangrieken, P., Leenders, P., Delhaas, T., Caiment, F., Kutmon, M., Trujillo, F. M., Wouters, K., Foulquier, S., Spronck, B., Reesink, K. D., & Schalkwijk, C. G. (2025). Glyoxalase-1 overexpression attenuates arterial wall stiffening in diabetic mice. Cardiovascular Diabetology, 24(1), Article 283. https://doi.org/10.1186/s12933-025-02823-4

Wong, L. Y., Torfs, T., Vanherle, S. J. V., Janssen, J., Claes, G. R. F., Stroeks, S. L. V. M., Willemars, M. M. A., Schianchi, F., Kapsokalyvas, D., Weltjens, E., Swinnen, A., Strzelecka, A., Krapels, I. P. C., Heymans, S. R. B., Glatz, J., van den Wijngaard, A., Brunner, H. G., Broers, J., Luiken, J. F. P., ... Nabben, M. (2025). Clinical and metabolic consequences of a historic pathogenic lamin A/C founder variant. Scientific Reports, 15(1), Article 23842. https://doi.org/10.1038/s41598-025-08495-0

Steiner, B., Verket, M., Baldewijns, K., Murphy, M., McNulty, A., Schwertfeger, M., Friedl, S., Barrett, M., Hill, L., Brandts, J., Romero, I., Helms, T. M., Brunner-La Rocca, H.-P., Zippel-Schultz, B., & iCARE4CVD Consortium (2025). Participative research for individualised care in cardiovascular diseases (PRIC-CVD): study protocol for a non-interventional, multicentre mixed-methods study as part of iCARE4CVD. BMJ Open, 15(7), Article e098061. https://doi.org/10.1136/bmjopen-2024-098061

Dheedene, W., Verhulst, S., Demuynck, L., Callewaert, B., de Haan, W., Vinckier, S., Van Wauwe, J., Vandervoort, P., Lox, M., Stroobants, M., Lavend'homme, R., van IJcken, W. F. J., Jones, E. A. V., Zwijsen, A., Jacquemin, M., van Grunsven, L. A., Martinod, K., Huylebroeck, D., Mulugeta, E., & Luttun, A. (2025). Loss of endothelial ZEB2 in mice attenuates steatosis early during metabolic dysfunction-associated steatotic liver disease. Scientific Reports, 15(1), Article 23434. https://doi.org/10.1038/s41598-025-05881-6

Kerneis, M., Ammirati, E., Delmas, C., Heggermont, W., Heymans, S., Lenz, M., Madonna, R., Morosin, M., Schaubroeck, H., Sionis, A., Tsaban, G., Uzokov, J., Vardanyan, K., Vandenbriele, C., & Roubille, F. (2025). Clinical Management of Acute myocarditis in daily practice: an expert practical view. European Heart Journal: Acute Cardiovascular Care, 14(7), 420-431. https://doi.org/10.1093/ehjacc/zuaf057

Malgie, J., Wilde, M. I., Brunner-La Rocca, H.-P., Emans, M. E., De Boer, G. A., Siegers, C. E. P., van Stipdonk, A. M. W., Wardeh, A. J., Schaap, J., Sanders-van Wijk, S., van den Heuvel, M., Wierda, E., De Boer, R. A., Koudstaal, S., & Brugts, J. J. (2025). Newly diagnosed heart failure with reduced ejection fraction: timing, sequencing, and titration of guideline-recommended medical therapy. European Heart Journal, 46(25), 2394-2405. https://doi.org/10.1093/eurheartj/ehaf244

Raman, J., Simmonds, S. J., Caluwé, E., van Leeuwen, R., Walschap, C., Stroobants, M., Cöl, Ü., Vandervoort, P., Heymans, S., & Jones, E. A. V. (2025). Ccr2+ Monocyte-Derived Macrophages Drive Cardiac Hypertrophy In Early Hfpef. American Journal of Physiology-heart and Circulatory Physiology, 329(1), H109-H123. https://doi.org/10.1152/ajpheart.00022.2025

Gingele, A. J., Steiner, B., Zippel-Schultz, B., & Brunner-La Rocca, H.-P. (2025). Adherence to eHealth Interventions Among Patients With Heart Failure: Scoping Review. JMIR mHealth and uHealth, 13, Article e63409. https://doi.org/10.2196/63409

Brunner-La Rocca, H.-P., Mueller-Wieland, D., Hovingh, G. K., & iCARE4CVD Consortium Investigators (2025). iCARE4CVD: an innovative European consortium aiming to improve personalized cardiovascular care. European Heart Journal, 46(23), 2139-2141. Article ehaf128. https://doi.org/10.1093/eurheartj/ehaf128

Dennis, K. M. J. H., Gopal, K., Montes Aparicio, C. N., Aaron Zhang, J., Castro-Guarda, M., Nicol, T., Devereux, R. M., Carter, R. D., Azizi, S. A., Lan, T., Purnama, U., Carr, C. A., Simsek, G., Gill, E. K., Swietach, P., Sorop, O., Heinonen, I. H. A., Schianchi, F., Luiken, J. J. F. P., ... Heather, L. C. (2025). FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in Diabetes. Circulation Research, 136(12), 1545-1560. https://doi.org/10.1161/CIRCRESAHA.124.325918

Van der Taelen, L., Briones, A. M., Unger, T., Staals, J., van Oostenbrugge, R. J., & Foulquier, S. (2025). Circulating immune cells in cerebral small vessel disease: a systematic review. Biogerontology, 26(3), Article 101. https://doi.org/10.1007/s10522-025-10250-x

da Costa Martins, P. A., Calore, M., & Kocken, J. M. M. (2025). Right ventricle remodelling: from in vitro to in vivo and from simple to complex models. Journal of Molecular and Cellular Cardiology Plus, 12, Article 100298. https://doi.org/10.1016/j.jmccpl.2025.100298

Sacchetto, C., Rabino, M., Paulis, M., Ferron, S., Bauce, B., Vitiello, L., Rampazzo, A., de Windt, L. J., Di Pasquale, E., & Calore, M. (2025). Generation of the human iPSC line UNIPDi006-A from a patient with arrhythmogenic cardiomyopathy carrying the DSG2 c.1672C > T pathogenic variant. Stem Cell Research, 85, Article 103695. https://doi.org/10.1016/j.scr.2025.103695

Weerts, J., Mourmans, S. G. J., Lopez-Martinez, H., Domingo, M., Aizpurua, A. B., Henkens, M. T. H. M., Achten, A., Lupon, J., Brunner-La Rocca, H.-P., Knackstedt, C., Bayes-Genis, A., & van Empel, V. P. M. (2025). Inter-atrial block as a predictor of adverse outcomes in patients with HFpEF. Esc heart failure, 12(3), 2287-2297. https://doi.org/10.1002/ehf2.15179

Herrmann, J. J., Brunner-La Rocca, H.-P., Baltussen, L. E. H. J. M., Beckers-Wesche, F., Bekkers, S. C. A. M., Bellersen, L., van Eck, J. W. M., Hassing, H. C., Jaarsma, T., Linssen, G. C. M., Pisters, R., Sanders-van Wijk, S., Verdijk, M. H. I., Handoko, M. L., van der Meer, P., Verbrugge, F. H., Januzzi Jr, J. L., Bayes-Genis, A., Nieuwlaat, R., ... van Kimmenade, R. R. J. (2025). Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial. Nature Medicine, 31(6), 2062-2068. https://doi.org/10.1038/s41591-025-03628-4

Achten, A., van Empel, V. P. M., Weerts, J., Mourmans, S., Brunner-La Rocca, H.-P., Sanders-van Wijk, S., & Knackstedt, C. (2025). Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fraction. Netherlands Heart Journal, 33(6), 193-198. https://doi.org/10.1007/s12471-025-01954-3

Helms, T. M., Boriani, G., Brunner-La Rocca, H.-P., Klein, C., Koehler, F., Krzesinski, P., Maaser, Y., Neumann, A., Merino, J. L., Schultz, C., Wright, D. J., Zippel-Schultz, B., & Hindricks, G. (2025). The present and future of cardiological telemonitoring in Europe: a statement from seven European countries. Herzschrittmachertherapie und Elektrophysiologie, 36(2), 138-148. https://doi.org/10.1007/s00399-025-01076-8

Lambrichts, S. M. P., van Oostenbrugge, R. J., & Foulquier, S. (2025). TRPV4 in Cerebral Small Vessel Disease: A key interacting partner. Vascular Pharmacology, 159, Article 107492. https://doi.org/10.1016/j.vph.2025.107492

Ghigo, A., Ameri, P., Asnani, A., Bertero, E., de Boer, R. A., Farmakis, D., González, A., Heymans, S., Ibáñez, B., López-Fernández, T., Lyon, A. R., Pollesello, P., Rakisheva, A., Stellos, K., Streckfuss-Bömeke, K., Tocchetti, C. G., Thum, T., van der Meer, P., Van Rooij, E., ... Van Linthout, S. (2025). Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart. European journal of heart failure, 27(6), 1028-1046. https://doi.org/10.1002/ejhf.3636

Wiethoff, I., Schoonvelde, S. A. C., de Boer, R. A., Evers, S. M. A. A., Germans, T., Hirsch, A., Knackstedt, C., Te Rijdt, W. P., van Slegtenhorst, M. A., Schinkel, A. F. L., Zwetsloot, P.-P., Michels, M., & Hiligsmann, M. (2025). Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study. Open Heart, 12(1), Article e003143. https://doi.org/10.1136/openhrt-2024-003143

Michel, L. Y. M., Esfahani, H., De Mulder, D., Verdoy, R., Ambroise, J., Roelants, V., Bouchard, B., Fabian, N., Savary, J., Dewulf, J. P., Doumont, T., Bouzin, C., Haufroid, V., Luiken, J. J. F. P., Nabben, M., Singleton, M. L., Bertrand, L., Ruiz, M., Des Rosiers, C., & Balligand, J.-L. (2025). An NRF2/β3-Adrenoreceptor Axis Drives a Sustained Antioxidant and Metabolic Rewiring Through the Pentose-Phosphate Pathway to Alleviate Cardiac Stress. Circulation, 151(18), 1312-1328. https://doi.org/10.1161/CIRCULATIONAHA.124.067876

Beelen, N. J., Vohra, J., & Verdonschot, J. A. J. (2025). Basic principles of genetics and genetic counselling. Indian pacing and electrophysiology journal, 25(3), 177-184. https://doi.org/10.1016/j.ipej.2025.05.002

Groeneweg, J. A., van Dalen, B. M., Cox, M. P. G. J., Heymans, S., Braam, R. L., Michels, M., & Asselbergs, F. W. (2025). 2023 European Society of Cardiology guidelines on the management of cardiomyopathies: Statement of endorsement by the NVVC. Netherlands Heart Journal, 33(5), 148-156. https://doi.org/10.1007/s12471-025-01955-2

Gingele, A. J., & Rocca, H.-P. B.-L. (2025). Enhancing heart failure detection and patient engagement with the Maastricht Decompensation Questionnaire. Netherlands Heart Journal, 33(5), 181. https://doi.org/10.1007/s12471-025-01945-4

Suthahar, N., Mourmans, S. G. J., Achten, A., Aboumsallem, J. P., Meijers, W. C., Bomer, N., Kardys, I., Gansevoort, R. T., Bakker, S. J. L., Weerts, J., Eringa, E. C., Damman, K., van Empel, V., & de Boer, R. A. (2025). Peroxiredoxin-4, a marker of systemic oxidative stress, is associated with incident heart failure. European journal of heart failure, 27(5), 905-911. Article 3653. https://doi.org/10.1002/ejhf.3653

Pinckaers, N. E. T., Blankesteijn, W. M., Mircheva, A., Punt, A., Opperhuizen, A., van Schooten, F.-J., & Vrolijk, M. (2025). Quantitative in vitro-to-in vivo extrapolation of human adrenergic and trace amine-associated receptor 1 potencies of pre-workout supplement ingredients using physiologically based kinetic modelling-based reverse dosimetry. Archives of Toxicology, 99(5), 1999-2021. https://doi.org/10.1007/s00204-025-03992-7